Figure 1From: Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma Representative images showing the KRAS mutation detected by the SNaPshot assay. A, a negative control sample with no mutation peak; this sample was from a confirmed patient with no mutation. B, a positive sample with a typical KRAS mutation peak (red arrow head).Back to article page